Disease-Free Interval and Tumor Stage Complementarily Predict the Biological Behavior of Recurrent Hepatocellular Carcinoma

被引：0
|
作者：
Junichi Shindoh
Masaru Matsumura
Masahiro Kobayashi
Miho Akabane
Satoshi Okubo
Masaji Hashimoto
机构：
[1] Toranomon Hospital,Hepatobiliary
[2] Okinaka Memorial Institute for Medical Disease,Pancreatic Surgery Division, Department of Gastroenterological Surgery
来源：
Annals of Surgical Oncology | 2023年 / 30卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3402 / 3410
页数：8
相关论文
共 50 条
  • [1] ASO Visual Abstract: Disease-Free Interval and Tumor Stage Complementarily Predict the Biological Behavior of Recurrent Hepatocellular Carcinoma
    Shindoh, Junichi
    Matsumura, Masaru
    Kobayashi, Masahiro
    Akabane, Miho
    Okubo, Satoshi
    Hashimoto, Masaji
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (06) : 3411 - 3412
  • [2] Stage and disease-free interval help select patients for surgical management of locally recurrent and metastatic adrenocortical carcinoma
    Lo, Winifred
    Ayabe, Reed I.
    Kariya, Christine M.
    Good, Meghan L.
    Steinberg, Seth M.
    Davis, Jeremy L.
    Ripley, Robert T.
    Hernandez, Jonathan M.
    JOURNAL OF SURGICAL ONCOLOGY, 2020, 121 (02) : 228 - 233
  • [3] Stage and Disease-Free Interval are Useful in Selecting Patients for Surgical Management of Locally Recurrent and Metastatic Adrenocortical Carcinoma
    Lo, W.
    Kariya, C.
    Good, M. L.
    Steinberg, S. M.
    Davis, J. L.
    Ripley, R. T.
    Hernandez, J. M.
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : S108 - S109
  • [4] Models to predict disease-free survival for hepatocellular carcinoma patients with surgical resections
    Lai, Yin
    Lee, Jin-Chiao
    Hung, Hao-Chien
    Cheng, Chih-Hsien
    Wu, Tsung-Han
    Lee, Chen-Fang
    Wu, Ting-Jung
    Chou, Hong-Shiue
    Chan, Kun-Ming
    Lee, Wei-Chen
    JOURNAL OF SURGICAL ONCOLOGY, 2020, 122 (07) : 1444 - 1452
  • [5] Disease-free Interval Is Associated with Oncologic Outcomes in Patients with Recurrent Gastrointestinal Stromal Tumor
    Sutton, Thomas L.
    Walker, Brett S.
    Billingsley, Kevin G.
    Sheppard, Brett C.
    Corless, Christopher L.
    Heinrich, Michael C.
    Mayo, Skye C.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (12) : 7912 - 7920
  • [6] Disease-free Interval Is Associated with Oncologic Outcomes in Patients with Recurrent Gastrointestinal Stromal Tumor
    Thomas L. Sutton
    Brett S. Walker
    Kevin G. Billingsley
    Brett C. Sheppard
    Christopher L. Corless
    Michael C. Heinrich
    Skye C. Mayo
    Annals of Surgical Oncology, 2021, 28 : 7912 - 7920
  • [7] Disease-free Interval after Primary Treatment Predicts Prognosis of Recurrent Endometrial Carcinoma
    Ueda, Yutaka
    Matsumura, Yuki
    Egawa-Takata, Tomomi
    Miyake, Takahito
    Miyatake, Takashi
    Yoshino, Kiyoshi
    Fujita, Masami
    Matsuzaki, Shinya
    Yokoyama, Takuhei
    Miyoshi, Yukari
    Yamasaki, Masato
    Enomoto, Takayuki
    Kimura, Tadashi
    ANTICANCER RESEARCH, 2010, 30 (10) : 4347 - 4352
  • [8] FIBROLAMELLAR HEPATOCELLULAR-CARCINOMA - THERAPEUTIC IMPLICATIONS OF A 10-YEAR DISEASE-FREE INTERVAL
    ANG, PT
    EVANS, H
    PAZDUR, R
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1991, 14 (02): : 175 - 178
  • [9] Neoadjuvant Radiotherapy improves overall Survival and Disease-free Interval in resectable hepatocellular Carcinoma with Portal Vein-Tumor Thrombosis
    Brunner, Thomas B.
    Croner, Roland S.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (02) : 194 - 196
  • [10] Does pathologic tumor volume in conventional renal carcinoma predict disease-free survival?
    Poon, SA
    Katz, MH
    Katz, AE
    Goluboff, ET
    Olsson, CA
    Benson, MC
    McKiernan, JM
    JOURNAL OF UROLOGY, 2005, 173 (04): : 267 - 267
12345